Details for Patent: 12,403,109
✉ Email this page to a colleague
Which drugs does patent 12,403,109 protect, and when does it expire?
Patent 12,403,109 protects SOTALOL HYDROCHLORIDE and is included in one NDA.
Summary for Patent: 12,403,109
| Title: | Sotalol hydrochloride dosing |
| Abstract: | The present invention provides novel methods of administering sotalol hydrochloride to patients in need thereof. |
| Inventor(s): | John Somberg, Brandon Ira Kashfian, Janos Molnar |
| Assignee: | Altathera Pharmaceuticals LLC |
| Application Number: | US17/725,189 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 12,403,109
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altathera Pharms Llc | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | SOLUTION;INTRAVENOUS | 022306-001 | Jul 2, 2009 | RX | Yes | Yes | 12,403,109 | ⤷ Start Trial | DOSING REGIMEN FOR INTRAVENOUS SOTALOL FOR ADMINISTRATION IN A FACILITY THAT CAN PROVIDE CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING AND CARDIAC RESUSCITATION. | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
